Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis
Joanna Kempska(Universität Hamburg), Karen Legler(Christian-Albrechts-Universität zu Kiel)
Cited by 10
Related Papers
The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells
|Cell Death and Disease|2018|40